| GA23670-5mg |
|
117442-29-2 |
Xenopsin-Related Peptide 2 (XP-2)
|
0 |
C60H88N16O10 |
|
|
|
| GA23669-25g |
|
— |
Xanthenyl linker resin (200-400 mesh, 0.4-0.7 mmol/g)
|
0 |
— |
|
|
|
| GA23669-5g |
|
— |
Xanthenyl linker resin (200-400 mesh, 0.4-0.7 mmol/g)
|
0 |
— |
|
|
|
| GA23669-1g |
|
— |
Xanthenyl linker resin (200-400 mesh, 0.4-0.7 mmol/g)
|
0 |
— |
|
|
|
| GA23668-100g |
|
— |
Wang resin (200-400 mesh, 0.80-1.20 mmol/g)
|
0 |
— |
|
|
|
| GA23668-25g |
|
— |
Wang resin (200-400 mesh, 0.80-1.20 mmol/g)
|
0 |
— |
|
|
|
| GA23668-5g |
|
— |
Wang resin (200-400 mesh, 0.80-1.20 mmol/g)
|
0 |
— |
|
|
|
| GA23667-100g |
|
— |
Wang resin (100-200 mesh, 0.80-1.20 mmol/g)
|
0 |
— |
|
|
|
| GA23667-25g |
|
— |
Wang resin (100-200 mesh, 0.80-1.20 mmol/g)
|
0 |
— |
|
|
|
| GA23666-5mg |
|
95050-90-1 |
VIP sulfoxide (human, mouse, rat)
|
0 |
C147H238N44O43S |
|
|
|
| GA23666-1mg |
|
95050-90-1 |
VIP sulfoxide (human, mouse, rat)
|
0 |
C147H238N44O43S |
|
|
|
| GA23665-1mg |
|
125093-93-8 |
|
0 |
C154H257N49O40S |
|
|
|
| GA23665-005mg |
|
125093-93-8 |
|
0 |
C154H257N49O40S |
|
|
|
| GA23664-1mg |
|
132326-74-0 |
Vesicular Stomatitis Virus Nucleoprotein (52-59)
|
0 |
C44H66N12O12 |
|
|
|
| GA23664-005mg |
|
132326-74-0 |
Vesicular Stomatitis Virus Nucleoprotein (52-59)
|
0 |
C44H66N12O12 |
|
|
|
| GA23663-5mg |
|
9047-55-6 |
|
0 |
C62H84N14O17S2 |
|
|
|
| GA23663-1mg |
|
9047-55-6 |
|
0 |
C62H84N14O17S2 |
|
|
|
| GA23662-1mg |
|
— |
Uroguanylin Topoisomer B (human)
|
0 |
C64H102N18O26S4 |
|
|
|
| GA23662-005mg |
|
— |
Uroguanylin Topoisomer B (human)
|
0 |
C64H102N18O26S4 |
|
|
|
| GA23661-1mg |
|
154525-25-4 |
Uroguanylin Topoisomer A (human)
|
0 |
C64H102N18O26S4 |
|
|
|
